Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Ipca Laboratories LimitedIpca Laboratories Limited
VS
NovartisNovartis
Ipca Laboratories Limited

Ipca Laboratories Limited

125 Kandivli Industrial Estate, Kandivli (West), Mumbai, Maharashtra, IN, 400067

Last Update: 02/04/2026

View Profile
Between 750 and 799
https://www.ipca.com/
768/1000Fair

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:13,559
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0
Novartis

Novartis

Novartis Campus, Basel, 4002, CH

Last Update: 20/05/2026

View Profile
Between 800 and 849
http://www.novartis.com
809/1000Good

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million pe...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:82,910
Subsidiaries:32
12-month incidents
1
Known data breaches
1
Attack type number
2

Compliance Ranges Comparison

Based On Specific Ai Models Category
Ipca Laboratories Limited

Ipca Laboratories Limited

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Novartis

Novartis

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Ipca Laboratories Limited in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Novartis has 3.85% fewer incidents than the average of all companies with at least one recorded incident.

Incidents

Incident History - Ipca Laboratories Limited (X = Date, Y = Severity)

Ipca Laboratories Limited cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Novartis (X = Date, Y = Severity)

Novartis cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Ipca Laboratories Limited

Ipca Laboratories Limited

Incidents
No explicit notable incidents reported.
Novartis

Novartis

Incidents
🔒 Incident : Breach
NOV1774449180
🔒 Incident : Cyber Attack
NOV21267722

FAQ

Between Ipca Laboratories Limited company and Novartis company, which one has the best AI Cybersecurity Score ?
Between Ipca Laboratories Limited company and Novartis company, which one has experienced more cyber incidents in the past ?
Between Ipca Laboratories Limited company and Novartis company, which one has experienced more cyber incidents this year ?
Between Ipca Laboratories Limited company and Novartis company, which one has experienced at least one ransomware attack ?
Between Ipca Laboratories Limited company and Novartis company, which one has experienced at least one data breach ?
Between Ipca Laboratories Limited company and Novartis company, which one has experienced at least one targeted cyberattack ?
Between Ipca Laboratories Limited company and Novartis company, which one has experienced at least one vulnerability ?
Between Ipca Laboratories Limited company and Novartis company, which one holds the most compliance certifications ?
Between Ipca Laboratories Limited company and Novartis company, which one holds the fewest compliance certifications ?
Between Ipca Laboratories Limited company and Novartis company, which one has the most subsidiaries ?
Between Ipca Laboratories Limited company and Novartis company, which one has the largest number of employees ?
Between Ipca Laboratories Limited and Novartis, which company holds both SOC 2 Type 1 certifications ?
Between Ipca Laboratories Limited and Novartis, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Ipca Laboratories Limited or Novartis ?
Which company is PCI DSS compliant - Ipca Laboratories Limited or Novartis ?
Between Ipca Laboratories Limited and Novartis, which company complies with HIPAA regulations for healthcare data ?
Between Ipca Laboratories Limited and Novartis, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-63261
SUMMARY

Uncontrolled Resource Consumption (CWE-400) in Kibana can lead to denial of service via Excessive Allocation (CAPEC-130). A low-privileged authenticated user can send a specially crafted request to a Kibana machine learning feature, causing the server to exhaust available memory and become unavailable to all users.

PUBLISHED
Date2026-07-21
UPDATED
Date2026-07-21
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
CVE-2026-63260
SUMMARY

Uncontrolled Resource Consumption (CWE-400) in Kibana can lead to denial of service via Excessive Allocation (CAPEC-130). An authenticated attacker with low-privilege access can trigger a denial of service condition in Kibana by sending a specially crafted, oversized request payload. Processing this user-supplied input requires resource-intensive memory allocation that can exhaust the available heap memory in the Kibana process, causing it to crash and become unavailable to all users.

PUBLISHED
Date2026-07-21
UPDATED
Date2026-07-21
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
CVE-2026-63259
SUMMARY

Authorization Bypass Through User-Controlled Key (CWE-639) in Kibana can lead to information disclosure via user-supplied identifiers that reference scheduled query result data from Kibana Spaces the requester is not authorized to access.

PUBLISHED
Date2026-07-21
UPDATED
Date2026-07-21
RISK INFORMATION (Score: 4.3)
CVSS3
Base Score: 4.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
IMPACT SCORE
1.4
EXPLOITABILITY
2.8
CVE-2026-63145
SUMMARY

Incorrect Authorization (CWE-863) in Kibana can lead to integrity compromise of Machine Learning audit and notification records via Accessing Functionality Not Properly Constrained by ACLs (CAPEC-1). A vulnerability exists in Kibana's Machine Learning functionality where a Machine Learning management endpoint performs an insufficient authorization check. The endpoint validates only a coarse privilege level but does not verify that the requesting user has access to the specific Machine Learning job or notification resources provided in the request. As a result, a low-privileged user with Machine Learning access in any Kibana space can manipulate Machine Learning audit and notification records for arbitrary jobs—including jobs in other spaces or belonging to other users—by leveraging Kibana's internally elevated credentials to write to restricted Machine Learning system indices that the user cannot access directly.

PUBLISHED
Date2026-07-21
UPDATED
Date2026-07-21
RISK INFORMATION (Score: 4.3)
CVSS3
Base Score: 4.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:L/A:N
IMPACT SCORE
1.4
EXPLOITABILITY
2.8
CVE-2026-63144
SUMMARY

Uncontrolled Recursion (CWE-674) in Elasticsearch can lead to denial of service via a specially crafted search request submitted by a low-privileged authenticated user. A user with read-level index access can submit a request that triggers unbounded recursive processing within the Elasticsearch query evaluation component, causing a fatal error that terminates the affected node. In single-node deployments, this results in complete service outage; in multi-node clusters, it causes repeated node restarts and sustained availability degradation.

PUBLISHED
Date2026-07-21
UPDATED
Date2026-07-21
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
2.8